Investigation of The Effect of Cenicriviroc (CVC) Plus FTC/TDF on Cardiovascular Disease Risk Factors

This study has been terminated.
(Low enrollment)
Tobira Therapeutics, Inc.
Information provided by (Responsible Party):
University of California, San Francisco Identifier:
First received: November 15, 2011
Last updated: May 8, 2015
Last verified: May 2015
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: December 2012
  Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)